



























Bb r a z i l i a n j o u r n a l o f m i c r o b i o l o g y 4 8 (2 0 1 7) 167–172
ht tp : / /www.bjmicrobio l .com.br /
edical Microbiology
razilian  borreliosis  with  special  emphasis  on
umans and  horses
oberta Carvalho Basilea,∗, Natalino Hajime Yoshinarib, Elenice Mantovanib,
irgínia  Nazário Bonoldib, Delphim da Grac¸a Macorisa, Antonio de Queiroz-Netoa
Universidade Estadual Paulista, Faculdade de Ciências Agrárias e Veterinárias, Jaboticabal, São Paulo, SP, Brazil
Universidade de São Paulo, Departamento de reumatologia, São Paulo, SP, Brazil
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 5 November 2015
ccepted 20 May 2016
vailable online 4 October 2016








a  b  s  t  r  a  c  t
Borreliosis caused by Borrelia burgdorferi sensu lato is a cosmopolitan zoonosis studied world-
wide;  it is called Lyme disease in many countries of the Northern Hemisphere and Lyme-like
or  Baggio-Yoshinari Syndrome in Brazil. However, despite the increasing number of suspect
cases, this disease is still neglected in Brazil by the medical and veterinary communities.
Brazilian Lyme-like borreliosis likely involves capybaras as reservoirs and Amblyomma and
Rhipicephalus ticks as vectors. Thus, domestic animals can serve as key carriers in pathogen
dissemination. This zoonosis has been little studied in horses in Brazil. The ﬁrst survey was
performed in the state of Rio de Janeiro, and this Brazilian Borreliosis exhibits many  differ-
ences from the disease widely described in the Northern Hemisphere. The etiological agent
shows different morphological and genetic characteristics, the disease has a higher recur-
rence rate after treatment with antibiotics, and the pathogen stimulates intense symptoms
such as a broader immune response in humans. Additionally, the Brazilian zoonosis is not
transmitted by the Ixodes ricinus complex. With respect to clinical manifestations, Baggio-
Yoshinari Syndrome has been reported to cause neurological, cardiac, ophthalmic, muscle,
and  joint alterations in humans. These symptoms can possibly occur in horses. Here, we
present a current panel of studies involving the disease in humans and equines, particularly
in  Brazil.
© 2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. This is
an  open access article under the CC BY-NC-ND license (http://creativecommons.org/
In 1976, children in a geographical region of the United States,yme disease (LD) or Lyme borreliosis (LB) is the most com-
on  tick-borne disease in temperate regions of the Northern
emisphere and is caused by the spirochete Borrelia burgdorferi
ensu lato.1 LD is a multistage disease that can affect multiple
rgans but in humans manifests predominantly in the skin,
oints, and nervous system.2
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Historyspeciﬁcally near the town of Lyme, Connecticut, were affected
by a mysterious syndrome3 that was initially diagnosed as
lsevier Editora Ltda. This is an open access article under the CC
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juvenile rheumatoid arthritis.1 In 1981, the entomologist and
physician Willy Burgdorfer, along with Alan Barbour and Jorge
Benach, found a spirochete in the midgut of ticks of the genus
Ixodes in an area of New York, a known endemic focus of LD.
The researchers cultivated samples from ticks in a culture
medium developed for growing the relapsing fever spirochete
(B. hermisii) and found a new species of Borrelia, subsequently
named B. burgdorferi.4 Later, the same bacterium was isolated
and cultivated from the blood of patients with LD.
The diseases termed Lyme borrelioses are known to be
caused by a large number of species related to B. burgdorferi,
which are called B. burgdorferi sensu lato.5 Of the 34 existing
Borrelia spp., 20 are referred to as Borrelia burgdorferi sensu lato
and cause LD, which is transmitted by ticks of the genus Ixodes.
Of these 20 species, only nine have been isolated from humans
in the Northern Hemisphere (B. afzelii,  B. bavariensis, B. bissetti,
B. burgdorferi stricto sensu, B. garinii,  B. kurtenbachii, B. lusitaniae,
B. spielmanii,  and B. valaisiana).6
The ﬁrst isolation of B. burgdorferi sensu lato in the Southern
Hemisphere was performed by Barbieri et al. in Uruguay from I.
pararicinus ticks. Thereafter, the bacterium was also identiﬁed
in Argentina7 and Chile,8,9 where it was named B. chilensis.
All three isolations revealed the bacterium in ticks of the I.
ricinus complex using ampliﬁcation of the 16S ribosomal gene,
5S-23S intergenic spacer, and ﬂagellin gene (ﬂa) for species
identiﬁcation.
B. burgdorferi sensu lato is a highly invasive gram-negative
spirochete. Its pathogenicity depends on its mobility, cyto-
toxicity, antigenic variability, lymphocyte stimulation, and
resistance to complement activation in the absence of speciﬁc
antibodies.10
Transmission
The pathogen is mainly transmitted by ticks of the I. rici-
nus complex.11 However, there are reports of B. burgdorferi
s.l. transmission by Amblyomma americanum in Florida and
Georgia in the United States.12 It has also been identiﬁed in
Dermacentor nitens in the state of Paraná, Brazil.13
The bacteria can infect the tick when it feeds on an infected
reservoir host.11 After molting to the nymph stage, the ticks
are able to transmit the pathogen to the animal from which it
obtains its next blood meal. As transtadial transmission is not
always successful, transmission of the bacteria is ensured by
an enzootic cycle in which the tick feeds on various vertebrate
hosts.14
The spirochetes are deposited into the bite wound along
with the tick saliva. For infection to succeed, the tick must
feed for at least 24 h adhered to the host, a period after which
there is reduced expression of Outer Surface Proteins A and
B (OspA and OspB) and increased expression of Outer Surface
Protein C (OspC). OspAs and OspBs are lipoproteins essential
for the survival of Borrelia spp. in the tick midgut. OspC is cru-
cial for establishing infection in the invertebrate host because
the protein allows the bacteria to migrate from the tick midgut
to the salivary glands, where they will be carried with the
saliva to the vertebrate host.15 OspC also has an important
role in the vertebrate host because it induces immunosup-
pression, thereby favoring infection.14 Tilly and co-workers16 b i o l o g y 4 8 (2 0 1 7) 167–172
found that bacteria lacking OspC do not establish infection in
mice by either bacterial inoculation via injection or by tick bite.
Immune  response
In the vertebrate host, Borrelia spp. are recognized by several
mechanisms of the immune response, including the comple-
ment system and diverse innate immune cells.17 Despite being
classiﬁed as gram negative, B. burgdorferi does not produce
lipopolysaccharide (LPS) but does express OspC in vertebrates.
Recognition of Borrelia spp. by dendritic cells leads to mat-
uration of these cells and triggers transcription of a large
set of genes, such as those expressing chemokines, apopto-
sis inhibitors, matrix metalloproteases and a large subset of
cytokines, including proinﬂammatory mediators, neutrophils
attractants, immunomodulatory cytokines.18
Following antigen presentation by dendritic cells, TH1
and TH2 lymphocyte helper T cells initiate the adaptive
response, promoting the release of interferon IFN- and inter-
leukin IL-4, which are directly related to the severity of
acute symptoms.17 Subsequently, the cytokines released by TH
cells induce B-lymphocyte proliferation of and consequently,
immunoglobulin production.18
Although the immune system attempts to prevent Borre-
lia infection, the spirochete has its own mechanisms to avoid
host defenses. Components of the tick’s saliva (such as Salp15)
are known to be able to suppress the dendritic cell response,
increasing the pathogenic virulence of Borrelia.17 The spiro-
chetes can also inactivate the host complement system by
binding to host complement regulatory proteins, thereby inac-
tivating the C3b mechanism. Another mechanism employed
by Borrelia to escape the immune response is antigenic vari-
ation. The variable major protein-like sequence gene locus
(vlsE) on plasmid 28-1 undergoes extensive variation, which
is stimulated by tick feeding.18
The  disease  in  humans  (LD  of  the  Northern
Hemisphere  versus  Brazilian  Baggio-Yoshinari
Syndrome)
Acute LD is typically manifested by an expanding ery-
thematous skin lesion. Late manifestations may include
arthritis, acrodermatitis chronica atrophicans, lymphocy-
toma, myocarditis, conjunctivitis, uveitis, and neurological
signs.19
The existence of borreliosis in humans in Brazil was ﬁrst
suggested by Dr. Yoshinari and co-workers20; however, the ﬁrst
case in the country was not diagnosed until 1992. The increas-
ing number of cases identiﬁed in Brazil show differences
from the disease that occurs in the Northern Hemisphere.21–24
In Brazil, the occurrence of Ixodes ticks (I. auritulus and I.
loricatus) is associated with parasitism of some birds and
Didelphis albiventris,25,26 which are not considered the prefer-
ential vectors for horses and humans. Clinically, despite the
occurrence of signs such as erythema migrans and the usual
systemic complications, the Brazilian disease progresses with
recurrences, especially if antibiotic treatment is initiated
later than three months after infection. Brazilian patients























































Cb r a z i l i a n j o u r n a l o f m i c 
ave been reported to have a high frequency of antibod-
es against different autologous cell components. Therefore,
razilian Borreliosis (BB) was initially called Lyme-like disease,
yme-like borreliosis or Baggio-Yoshinari syndrome (BYS) to
istinguish it from the classical disease.27
In addition, studies conducted in the Laboratory of
heumatology of the Clinical Hospital of the School of
edicine, University of São Paulo (LIM-17 Hospital das Clíni-
as – Faculdade de Medicina, Universidade de São Paulo –
MUSP) showed the occurrence of microorganisms with mor-
hological structures similar to Mycoplasma spp., Chlamydia
pp., and non-ﬂagellated spirochetes in the peripheral blood
f patients with BYS who  were seropositive for B. burgdor-
eri sensu lato. However, those patients exhibited negative
erology for Mycoplasma spp. and Chlamydia spp., suggesting
 morphological difference between B. burgdorferi sensu lato
nd the Brazilian microorganism identiﬁed as the possible
ausative agent of BYS.28 Because motile and spiral spiro-
hetes were never isolated or cultured in Brazil, researchers
rom LIM-17 assumed that the etiological agent in Brazil was
resent in cystic form.
Due to these reasons, BB is deﬁned as an emerging tick-
orne disease, different from LD, caused by B. burgdorferi sensu
ato with atypical morphologies and transmitted by ticks not
elonging to Ixodes.  It is possible that Borrelia bacterial passage
hrough ticks from Amblyomma, Rhipicephalus, and Dermacen-
or genera can result in spirochete morphologic and genetic
odiﬁcations in both vertebrate and invertebrate hosts, thus
riginating a new disease similar to LD.28
BYS differs from LD because the disease has higher mor-
idity due to the presence of symptom recurrence, severe
eactive manifestations such as autoimmunity, and the need
or prolonged treatment. Laboratory diagnosis of BYS is difﬁ-
ult because serological tests (ELISA, enzyme immunosorbent
ssay, or western blotting) for B. burgdorferi show low sensi-
ivity and speciﬁcity27–32; this is because these tests utilize
ntigens from B. burgdorferi stricto sensu from the North-
rn Hemisphere to evaluate immunoglobulins of Brazilian B.
urgdorferi sensu lato.
BYS can cause some symptoms similar to those observed
n LD, including erythema migrans in approximately 50% of
atients, arthritis in 35%, neurological symptoms in 35%, and
ardiac disease in nearly 5%. The disease is often unrecog-
ized, especially at secondary or tertiary stages when patients
o not remember what occurred months or years before
he current disease. Certainly, many  cases of unrecognized
hronic neurological or articular disease are in fact cases of
YS not identiﬁed and treated at early stages.28
The ﬁrst studies in Brazil to report the occurrence of B.
urgdorferi sensu lato were published in 2010, when dermatol-
gists used immunohistochemistry to identify the spirochete
n skin biopsies of the erythema migrans from four patients.33
n a subsequent study employing immunohistochemistry and
ocus ﬂoating microscopy, Talhari and co-workers34 also iden-
iﬁed the bacterium in skin lesions from 22 patients. Despite
onducting nested-PCR (polymerase chain reaction) using a
et of four primers (external primers, 1 – AAG ACG AAG ATA
TC GAT CTG TAA TTG and 2 – TTG CAG AAT TTG ATA AAG
TG G, and internal primers, 3 – TCT GTA ATT GCA GAA ACA
CT and 4 – GAG TAT GCT ATT GAT GAA TTA TTG), none ofo l o g y 4 8 (2 0 1 7) 167–172 169
the 22 samples was positive. Therefore, standardizing a PCR
technique for identiﬁcation of the Borrelia bacteria occurring
in Brazil remains a challenge.
Mantovani and co-workers35 demonstrated the presence
of spirochetes of genus Borrelia in the blood of human
patients with BB by performing ﬂgE gene ampliﬁcation
(470 FW 5′-CGCCTATTCTAACTTGACCCGAAAT-3′ and 470 Rev
5′-TTAGTGTTCTTGAGCTTAGAGTTG-3′) as well as in genus
Rhipicephalus ticks. Similarly, Gonc¸alves et al. identiﬁed B.
burgdorferi s.l. strain B31 in D. nitens ticks collected on a
horse in Paraná State (nested-PCR targeting the 5S (rrf) 23S
(rrl) intergenic spacer region, 99.9% BLAST similarity with B.
burgdorferi s.s.). Additionally, the same research group identi-
ﬁed B. burgdorferi sensu lato in the blood of humans from a
rural area in Paraná State (nested-PCR targeting the 5S (rrf)
23S (rrl) intergenic spacer region, 100% BLAST similarity with
B. burgdorferi s.s.).36 However, phylogenetic analysis was not
performed in either study, leaving many  uncertainties about
the classiﬁcation of the Brazilian pathogen(s).
Recent studies show the possibility of ticks of the genera
Amblyomma and Rhipicephalus being directly related to dissem-
ination of the disease. Rezende and co-workers37 reported that
embryonic cells of R. microplus and A. sculptum (previously
cajennense according to the new taxonomic status38) could
serve as substrate for the growth of B. burgdorferi sensu stricto
strain G39/40. B. burgdorferi sensu lato was identiﬁed in A. amer-
icanum ticks collected from LD patients diagnosed by ELISA
and PCR in Florida, USA.12
Borreliosis  in  horses
B. burgdorferi sensu lato is capable of infecting wild and domes-
tic animals. Additionally, domestic animals, such as dogs,
cattle, and horses, can be carriers of this pathogen. Unlike the
unapparent disease observed in wild animals, this etiologi-
cal agent is capable of causing clinical symptoms in domestic
animals.39–42
Based on indirect ELISA and Western blotting, it was
observed that horses exposed to ticks have a higher fre-
quency of seropositivity for B. burgdorferi sensu lato than
horses subjected to strict tick control.43 In addition, viable Bor-
relia bacteria have been found in the urine of healthy horses
in an endemic region of the United States,44 warning of the
possibility agent transmission by contact routes in addition
to tick bites. Chang and co-workers validated an equine LD
model by exposing ponies to ticks harboring B. burgdorferi for
seven days. They then evaluated the antibody response and
treatment efﬁcacy at 120 days after infection and found that
the antibody levels of the treated animals returned to negative
levels in 10 months.45,46
In Brazil, it was detected an average ELISA seropositiv-
ity of 9.8% in horses in the state of Rio de Janeiro, and in
the municipality of Seropédica, the frequency was 42.8%.43
Madureira and co-workers47 observed a frequency of 28.4%
of anti-Borrelia homologous ELISA antibodies in horses in
the municipalities of Três Rios and Vassouras, Rio de Janeiro
State, whereas the frequency was 26.7% in the municipality of
Belém, Pará State.48 Guedes Junior and co-workers49 identiﬁed
54.9% of cattle as being seropositive in the state of Paraná. In
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dogs, the rate of seropositivity was 48.25% in Rio de Janeiro
city.50 The occurrence of LD in wild animal veterinarians and
found 6.4% seropositivity for B. burgdorferi s.l. in São Paulo
city.51
Borreliosis in horses remains underdiagnosed and poorly
understood by veterinarians. According to a survey conducted
in Germany of 118 veterinarians, only 56% believe that Lyme
borreliosis can affect horses. When asked about the number
of animals diagnosed in Germany, 45% answered that no ani-
mals are being diagnosed. Regarding control of the parasite,
46.5% stated that owners rarely perform ectoparasite control
measures. A relatively large percentage of the veterinarians
(30.5%) said that they would conﬁrm the diagnosis only by
serology and would not perform serological monitoring over
time. They also indicated that they would treat positive ani-
mals with antibiotics and anti-inﬂammatory medication (54%)
and stated that 71% of the horse owners are unaware of the
disease.52
Studies indicate that LB in horses has clinical signs
similar to the disease in humans,53 including fever and
lethargy,54 arthritis,55 polysynovitis,56 lameness, muscle
stiffness,57 abortion,54 meningitis, cranial neuritis, radicu-
loneuritis and encephalitis,58,59 uveitis,55,60,61 and premature
death of foals.54
To study spirochete distribution in horses, Chang and
co-workers experimentally infected eight ponies using I.
scapularis ticks infected with B. burgdorferi.  The ponies were
euthanized approximately nine months after infection, and
samples from several tissues, such as lymph nodes, skin,
muscles, synovial capsule, and meninges, were subjected to
molecular tests using primers targeting the ospA gene and the
23S ribosomal gene as well as cell culture. B. burgdorferi was
mainly detected from the skin, fascia, and muscle.45
Diagnosis
The gold standard for laboratory diagnosis of LB is serologi-
cal tests (ELISA conﬁrmed by Western blotting). However, an
increasing number of studies demonstrate the potential of
molecular and culture tests as a tool for diagnosis. The ﬁnal
diagnosis in humans is often based on symptoms, exposure
to ticks and serological tests.62 For many  other species of bac-
teria, the gold standard for identiﬁcation is culture. However,
Borrelia species can only grow under specialized culture con-
ditions, such as Barbour-Stoenner-Kelly (BSK) medium with
incubation at 30 ◦C to 35 ◦C for as many  as 12 weeks under
microaerophilic conditions. If a PCR method is chosen, results
obtained from skin biopsies from patients with classic ery-
thema migrans are more  sensitive than are samples of blood
collected from the same patients.63
The laboratory methods used for diagnosis of LB are the fol-
lowing: culture in Kelly medium of clinical samples from skin,
cerebrospinal ﬂuid, synovial ﬂuid, and blood; molecular detec-
tion using tissue specimens (targeting p66, 16S rRNA, ﬂagellar
gene ﬂa,  23S rRNA, and ospA genes and the 5S rRNA-23S
rRNA intergenic spacer using nested or real-time quantitative
PCR); and antibody detection such as enzyme immunoassays
(ELISA), indirect immunoﬂuorescent antibody assays (IFAs),
western blotting, and peptide-based immunoassays.64 b i o l o g y 4 8 (2 0 1 7) 167–172
Lyme disease in horses must be diagnosed based on (1) the
possibility of exposure to ticks infected with B. burgdorferi, (2)
clinical signs compatible with LD, (3) absence of other causes
for the clinical signs, and (4) a high titer of anti-B. burgdorferi
antibodies.65 The most common technique used for diagnos-
ing B. burgdorferi in humans and horses is antibody detection,
and the most frequently used techniques are IFA, Western
blotting, and ELISA, with the latter having greater applicabil-
ity for horses because it is faster and cheaper.66 Speciﬁcity
tests for IFA and ELISA show minimal cross-reactivity with
anti-Leptospira antibodies.67,68 In general, due to the slow mul-
tiplication of the spirochete in the host, three to six weeks
may be required for detection of immunoglobulin G (IgG)
titers, with eight to sixteen weeks needed to reach their
maximum.43,45,46 However, because the speciﬁcity of IFA and
ELISA tests is still questionable, a positive result must be
conﬁrmed by a second diagnostic method. Western blotting
is typically used to detect antibodies against Borrelia-speciﬁc
antigens69; alternatively, some researchers have used PCR,
which has the highest sensitivity and speciﬁcity.46,66
Chandrashekar and co-workers evaluated the feasibility of
using a commercial enzyme immunoassay kit developed for
dogs (SNAP® 4Dx) for the detection of anti-C6 peptide antibod-
ies in 160 horses infected by B. burgdorferi and previously tested
by western blotting (QualiCodeTM IgG/IgM Western Blot Kits,
Immunetics Inc., Boston, MA). The kit showed 100% speciﬁcity
and 95% sensitivity compared to the gold standard serological
test, and the authors indicated that the kit is a rapid and safe
test for the diagnosis of borreliosis in horses in the ﬁeld.70
A subsequent study found that serological tests using an
anti-C6 commercial kit (SNAP® 4Dx) could identify most of the
horses infected; however, it also produced false positive and
false negative results. In addition, serological tests for detect-
ing anti-C6 peptide antibodies and OspC and OspF, which are
associated with clinical signs, were found to consistently sup-
port the diagnosis of borreliosis in horses.71
Equine  therapeutics
Treatment with oxytetracycline (6.6 mg/kg, IV, every 12 h) for
three weeks was more  effective than the use of doxycycline
(10 mg/kg, VO, every 12 h) or ceftiofur (2.2 mg/kg, IM,  every
12 h). Oxytetracycline was the only antibiotic that led to neg-
ative results both according to culture and tissue PCR (lymph
nodes, skin, muscle fascia, synovial membranes, pericardium,
and meninges) at the end of treatment. Oxytetracycline can be
administered (5.0 mg/kg, IV, every 24 h) for four weeks, with
high efﬁcacy against B. burgdorferi in experimentally infected
ponies.46 Divers and co-workers found that tetracycline is
effective for treating LB in naturally infected horses (6.6 mg/kg,
IV, every 24 h).65
Final  remarksLD is a condition of extreme importance because it is a zoono-
sis that causes physical and psychological sequelae in affected
individuals. It remains poorly investigated in Brazil, espe-
cially in the ﬁeld of veterinary medicine. Therefore, studies
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escribing the unique aspects of the disease in Brazil and the
tiological agents found are needed.
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